Skip to main content
Skip to footer

Teaching Pharmacovigilance to Machines

Dr. Ashish Indani

Head, Research & Innovation, TCS ADD Life Sciences Platform

Dr. Aparna Patkar

Delivery Head and Sr. Domain Consultant, TCS Life Sciences

Devraj Goulikar

Head of Safety Solutions, TCS ADD Life Sciences Platform

You have these already downloaded

We have sent you a copy of the report to your email again.

Artificial intelligence in pharmacovigilance (PV) has the potential to disrupt life sciences industry while making the process quicker and data driven. This paper explores the role of AI in PV with special emphasis on ‘learning’-based observational processing. The system bundles the proprietary best-in-class natural language processing (NLP) and AI technologies capable of cleaning and contextually analyzing PV data identifying trends and outliers, including signals that can impact patient safety. Leveraging a combination of rule-based deterministic and probabilistic approaches to abstract patient data, medical events, drug, and reporter information. The most efficient results are produced when AI and PV professionals work closely in a symbiotic relationship where the bulk-processing is handled by AI systems, thus contributing to precise, quick, and informed decision-making by the pharmacovigilance professionals (PVP).

Related reading

Transparent AI in Pharmacovigilance and its Importance

White Paper | 20 Oct 2022

Standardization of Data Transfer Agreements & Automation in EDC

White Paper | 28 Sep 2022

Smart Medication for Enabling Patient Centricity

video | 19 Sep 2022

Merck renews its regulatory compliance strategy

Case Studies | 22 Aug 2022